While Ghasemi’s study underscores the role of COX-2 as a key marker for melanoma diagnosis, our research suggests that examining COX-2 alongside SMA can aid in comprehending the behavior and characteristics of different BCC subtypes. This evidence concerns the gene PTGS2 and melanoma.